Skip to main content

ADVANCED

 

CELL THERAPY
SOLUTIONS

Our expertise in biology, robotics, in silico analysis and
bioinformatics helps cell therapy pioneers advance the
discovery phase of their clinical candidates.

Advanced

SLIM DISPLAY FOR
CAR-T DISCOVERY

OXGENE’s proprietary CAR-T / antibody discovery platform targets challenging membrane proteins for the development of your CAR-T and other biologics. Antibody humanisation, affinity maturation and complex gene editing complete our discovery workflow.

Advanced

TRANSIENT LV
PRODUCTION SYSTEMS

Our optimised third generation packaging plasmids and clonal HEK293 cell line provide enhanced safety and increased lentiviral yield. 

COMING SOON

PROMOTER
DISCOVERY

Proprietary bioinformatics aid the rational design of combinatorial promoter / enhancer libraries that we screen for optimal promoter combinations designed to your specifications. 

Advanced

PLASMIDS AND
CELL LINES

Our optimised XLenti™ plasmid system delivers improved yield, quality and safety. Our cell line development services are underpinned by expertise in molecular biology and genetic engineering and supported by state of the art automation.

Advanced

LV PACKAGING AND PRODUCER CELL LINES

Stable clonal XLenti™ packaging and promoter cell lines offer easy scale up, reduced cost of goods and reduced process complexity. 

OXGENE's advanced technology and service solutions
help pioneering companies accelerate the discovery
phase of breakthrough cell and gene therapies.

RYAN CAWOOD, CHIEF SCIENTIFIC OFFICER, OXGENE & WuXi ATU

 

OXGENE provides an integrated solution that
supports your entire discovery and validation workflow

 

Our Publications

 

Are you ready for GMP Manufacture?

WuXi Advanced Therapies is a global Contract Testing, Development
and Manufacturing Organization (CTDMO) dedicated to accelerating
progress and time to market for cell and gene therapies.

×